Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies

Mammalian Genome

Volumn 23, Issue 1-2, 2012, Pages 85-108

  Kornegay, Joe N ^a   Bogan, Janet R ^a   Bogan, Daniel J ^a   Childers, Martin K ^c   Li, Juan ^a,b   Nghiem, Peter ^d   Detwiler, David A ^a   Larsen, C Aaron ^e   Grange, Robert W ^f   Bhavaraju Sanka, Ratna K ^a,j   Tou, Sandra ^g   Keene, Bruce P ^g   Howard Jr , James F ^a   Wang, Jiahui ^a   Fan, Zheng ^a   Schatzberg, Scott J ^h   Styner, Martin A ^a   Flanigan, Kevin M ⁱ   Xiao, Xiao ^a,b   Hoffman, Eric P ^d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNC Hamner Institute for Drug Safety Sciences   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^g NORTH CAROLINA STATE UNIVERSITY   (United States)

^h Veterinary Emergency and Specialty Center of Santa Fe   (United States)

ⁱ NATIONWIDE CHILDREN S HOSPITAL   (United States)

^j UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; CALPASTATIN; CHIMERIC OLIGONUCLEOTIDE; DYSTROPHIN; MESSENGER RNA; MINIDYSTROPHIN; MYOSTATIN; OLIGONUCLEOTIDE; PARVOVIRUS VECTOR; PLACEBO; POLOXAMER; PREDNISONE; SMALL NUCLEAR RNA; UNCLASSIFIED DRUG; UTROPHIN;

ARTICLE; BONE ATROPHY; BONE STRENGTH; BREED DIFFERENCE; CELL THERAPY; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; DOG; DRUG MEGADOSE; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROMYOGRAPHY; GAIT; GENE EXPRESSION PROFILING; GENE MUTATION; HEART DISEASE; HISTOPATHOLOGY; HUMAN; JOINT ANGLE; JOINT CONTRACTURE; MODIFIER GENE; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE FORCE; MUSCULOSKELETAL SYSTEM EXAMINATION; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHENOTYPIC VARIATION; PROTEIN DEPLETION; STEM CELL TRANSPLANTATION; TORQUE; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; X CHROMOSOME RECESSIVE DISORDER;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DOGS; DYSTROPHIN; JOINTS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE;

ANIMALIA; CANIS FAMILIARIS;

EID: 84857374252     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-011-9382-y     Document Type: Article

References (172)

1. CE Ambrósio MC Valadares E Zucconi R Cabral PL Pearson TP Gaiad M Canovas M Vainzof MA Miglino M Zatz 2008 Ringo, a Golden Retriever Muscular Dystrophy (GRMD) dog with absent dystrophin but normal strength Neuromuscul Disord 18 892 893 10.1016/j.nmd.2008.06.385
2. CE Ambrósio L Fadel TP Gaiad DS Martins KP Araujo E Zucconi MP Brolio RF Giglio AC Morini T Jazedje TR Froes ML Feitosa MC Valadares PC Beltrao-Braga FV Meirelles MA Miglino 2009 Identification of three distinguishable phenotypes in golden retriever muscular dystrophy Genet Mol Res 8 389 396 10.4238/vol8-2gmr581
3. MA Badalamente A Stracher 2000 Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition Muscle Nerve 23 106 111 10590413 1:CAS:528:DC%2BD3cXlsV2kug%3D%3D 10.1002/(SICI)1097-4598(200001)23:1<106:: AID-MUS14>3.0.CO;2-D
4. WI Baltzer DV Calise JM Levine GD Shelton JF Edwards JM Steiner 2007 Dystrophin-deficient muscular dystrophy in a Weimaraner J Am Anim Hosp Assoc 43 227 232 17615404
5. I Barthélémy E Barrey JL Thibaud A Uriarte T Voit S Blot JV Hogrel 2009 Gait analysis using accelerometry in dystrophin-deficient dogs Neuromuscul Disord 19 788 796 19800232 10.1016/j.nmd.2009.07.014
6. I Barthélémy E Barrey P Aguilar A Uriarte M Le Chevoir JL Thibaud T Voit S Blot JY Hogrel 2011 Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs BMC Musculoskelet Disord 12 75 21489295 10.1186/1471-2474-12-75
7. RJ Bartlett S Stockinger MM Denis WT Bartlett L Inverardi TT Le NT Man GE Morris DJ Bogan J Metcalf-Bogan JN Kornegay 2000 In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide Nat Biotech 18 615 622 1:CAS:528:DC%2BD3cXkt12gtLw%3D 10.1038/76448
8. AH Beggs M Koenig FM Boyce LM Kunkel 1990 Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction Hum Genet 86 45 48 2253937 1:CAS:528:DyaK3MXkvVKlurY%3D 10.1007/BF00205170
9. AH Beggs EP Hoffman JR Snyder K Arahata L Specht F Shapiro C Angelini H Sugita LM Kunkel 1991 Exploring the molecular basis for variability among patients with Becker muscular dystrophy: Dystrophin gene and protein studies Am J Hum Genet 49 54 67 2063877 1:STN:280:DyaK3M3ptVSltw%3D%3D
10. Bish LT, Sleeper MM, Forbes SC, Morine KJ, Reynolds C, Singletary GE, Trafny D, Bogan J, Kornegay JN, Walter GA, Sweeney HL (2011a) Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy. Hum Gene Ther, Jul 25, 2011 [Epub ahead of print]
11. Bish LT, Sleeper MM, Forbes SC, Wang B, Reynolds C, Singletary GE, Trafny D, Morine KJ, Sanmiguel J, Cecchini S, Virag T, Vulin A, Beley C, Bogan J, Wilson JM, Vandenborne K, Kornegay JN, Walter GA, Kotin RM, Garcia L, Sweeney HL (2011b) Long-term restoration of cardiac dystrophin expression in Golden Retriever Muscular Dystrophy following rAAV6-mediated exon skipping. Mol Ther, Dec 6, 2011 [Epub ahead of print]
12. KN Boddy BM Roche DS Schwartz T Nakayama RL Hamlin 2004 Evaluation of the six-minute walk test in dogs Am J Vet Res 65 311 313 15027678 10.2460/ajvr.2004.65.311
13. G Bonuccelli F Sotgia F Capozza E Gazzerro C Minetti MP Lisanti 2007 Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice Cell Cycle 6 1242 1248 17495527 1:CAS:528:DC%2BD2sXpvFGgsr4%3D 10.4161/cc.6.10.4182
14. AH Bretag 2007 Stem cell treatment of dystrophic dogs Nature 450 7173 E23 18097347 1:CAS:528:DC%2BD2sXhsVGjs7fE 10.1038/nature06437 discussion E23-E25
15. MH Brooke GM Fenichel RC Griggs JR Mendell R Moxley JP Miller MA Province 1983 Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history Muscle Nerve 6 91 103 6343858 1:STN:280:DyaL3s3hvFSlsw%3D%3D 10.1002/mus.880060204
16. JW Brumitt SC Essman JN Kornegay P Graham WJ Weber CR Berry 2006 Radiographic features of Golden Retriever muscular dystrophy Vet Radiol Ultrasound 47 574 580 17153067 10.1111/j.1740-8261.2006.00188.x
17. Buchthal F, Rosenfalck P (1963) Electrophysiologic aspects of myopathy with particular reference to progressive muscular dystrophy. In: Bourne GH, Golarz MN (eds) Muscular Dystrophy in Man and Animals. Hafner Publishing Company, New York, pp 193-243
18. G Bulfield WG Siller PAL Wight KJ Moore 1984 X chromosome-linked muscular dystrophy (mdx) in the mouse Proc Natl Acad Sci USA 81 1189 1192 6583703 1:CAS:528:DyaL2cXitVOnu78%3D 10.1073/pnas.81.4.1189
19. CT Caskey RL Nussbaum LC Cohan L Pollack 1980 Sporadic occurrence of Duchenne Muscular Dystrophy: evidence for new mutation Clin Genet 18 329 341 7460369 1:STN:280:DyaL3M7ht1Okuw%3D%3D 10.1111/j.1399-0004.1980.tb02293.x
20. M Cerletti T Negri F Cozzi R Colpo F Andreetta D Croci KE Davies F Cornelio O Pozza G Karpati R Gilbert M Mora 2003 Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer Gene Ther 10 750 757 12704413 1:CAS:528:DC%2BD3sXivFGqtrY%3D 10.1038/sj.gt.3301941
21. JV Chakkalakal J Thompson RJ Parks BJ Jasmin 2005 Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies FASEB J 19 880 891 15923398 1:CAS:528:DC%2BD2MXkvVamtL0%3D 10.1096/fj.04-1956rev
22. YW Chen P Zhao R Borup EP Hoffman 2000 Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiology J Cell Biol 151 1321 1336 11121445 1:CAS:528: DC%2BD3cXovFantb4%3D 10.1083/jcb.151.6.1321
23. V Chetboul C Carlos S Blot JL Thibaud C Escriou R Tissier JL Retortillo JL Pouchelon 2004 Tissue Doppler assessment of diastolic and systolic alterations of radial and longitudinal left ventricular motions in golden retrievers during the preclinical phase of cardiomyopathy associated with muscular dystrophy Am J Vet Res 65 1335 1341 15524319 10.2460/ajvr.2004.65.1335
24. MK Childers JN Kornegay R Aoki L Otaviani DJ Bogan G Petroski 1998 Evaluating motor endplate-targeted injections of botulinum toxin type A in a canine model Muscle Nerve 21 653 655 9572248 1:STN:280:DyaK1c3jtF2muw%3D%3D 10.1002/(SICI)1097-4598(199805)21:5<653::AID-MUS15>3.0.CO;2-W
25. MK Childers CS Okamura DJ Bogan JR Bogan MJ Sullivan JN Kornegay 2001 Myofiber injury and regeneration in a canine homologue of Duchenne muscular dystrophy Am J Phys Med Rehabil 80 175 181 11237271 1:STN:280: DC%2BD3M7otlKqug%3D%3D 10.1097/00002060-200103000-00004
26. MK Childers CS Okamura DJ Bogan JR Bogan GF Petroski K McDonald JN Kornegay 2002 Eccentric contraction injury in dystrophic canine muscle Arch Phys Med Rehabil 83 1572 1578 12422328 10.1053/apmr.2002.35109
27. Childers MK, Grange RW, Kornegay JN (2011) In vivo canine muscle function assay. J Vis Exp (50). pii 2623
28. Childers MK, Bogan JR, Bogan DJ, Greiner H, Staley J, Holder M, Grange RW, Kornegay JN Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of Duchenne muscular dystrophy. Front Integ Regen Pharmacol, in press
29. S Cirak V Arechavala-Gomeza M Guglieri L Feng S Torelli K Anthony S Abbs ME Garralda J Bourke DJ Wells G Dickson MJ Wood SD Wilton V Straub R Kole SB Shrewsbury C Sewry JE Morgan K Bushby F Muntoni 2011 Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study Lancet 378 9791 595 605 21784508 1:CAS:528: DC%2BC3MXhtVWmtL%2FO 10.1016/S0140-6736(11)60756-3
30. DN Clements SD Carter JF Innes WER Ollier PJR Day 2007 Gene expression profiling of normal and ruptured canine anterior cruciate ligaments Osteoarthr Cartil 16 195 203 17702611 10.1016/j.joca.2007.06.013
31. DM Connuck LA Sleeper SD Colan GR Cox JA Towbin AM Lowe JD Wilkinson EJ Orav L Cuniberti BA Salbert SE Lipshultz 2008 Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: A comparative study from the Pediatric Cardiomyopathy Registry Am Heart J 15 998 1005 10.1016/j.ahj.2008.01.018
32. BJ Cooper WN Winand H Stedman BA Valentine EP Hoffman LM Kunkel M-O Scott KH Fischbeck JN Kornegay RJ Avery JR Williams RD Schmickel JE Sylvester 1988 The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs Nature 334 154 156 3290691 1:CAS:528:DyaL1cXlt1emsLc%3D 10.1038/334154a0
33. S Corti S Strazzer R Del Bo S Salani P Bossolasco F Fortunato F Locatelli D Soligo M Moggio P Ciscato A Prelle C Borsotti N Bresolin G Scarlato GP Comi 2002 A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse Exp Cell Res 277 74 85 12061818 1:CAS:528:DC%2BD38XksVeqtbY%3D 10.1006/excr.2002.5543
34. J Cowan J Macdessi A Start G Morgan 1980 Incidence of Duchenne muscular dystrophy in New South Wales and the Australian Capital Territory J Med Genet 17 245 249 7205898 1:STN:280:DyaL3M7ksFajtQ%3D%3D 10.1136/jmg.17.4.245
35. GR Cox LM Kunkel 1997 Dystrophies and heart disease Curr Opin Cardiol 12 329 343 9243091 1:STN:280:DyaK2szoslShug%3D%3D 10.1097/00001573-199705000-00015
36. F Cozzi M Cerletti GC Luvoni R Lombardo PG Brambilla S Faverzani F Blasevich F Cornelio O Pozza M Mora 2001 Development of muscle pathology in canine X-linked muscular dystrophy. II. Quantitative characterization of histopathological progression during postnatal skeletal muscle development Acta Neuropathol 101 469 478 11484818 1:STN:280:DC%2BD38%2FisFWnsw%3D%3D
37. D Cros P Harnden JF Pellissier G Serratrice 1989 Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study J Neurol 236 43 47 2915226 1:STN:280:DyaL1M7isV2qtw%3D%3D 10.1007/BF00314217
38. L De Angelis L Berghella M Coletta L Lattanzi M Zanchi MG Cusella-De Angelis C Ponzetto G Cossu 1999 Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration J Cell Biol 147 869 878 10562287 10.1083/jcb.147.4.869
39. AR de Lima JR Nyengaard AAL Jorge JCC Balieiro C Peixoto ET Fioretto CE Ambrósio MA Miglino M Zatz AACM Ribeiro 2007 Muscular dystrophy-related quantitative and chemical changes in adenohypophysis GH-cells in golden retrievers Growth Horm IGF Res 2007 489 491
40. C Dell'Agnola Z Want R Storb SJ Tapscott CS Kuhr SD Hauschka RS Lee GE Sale E Zellmer S Gisburne J Bogan JN Kornegay BJ Cooper TA Gooley M-T Little 2004 Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs Blood 104 4311 4318 15328150 10.1182/blood-2004-06-2247 1:CAS:528:DC%2BD2cXhtFaisrrJ
41. KM Dent DM Dunn AC von Niederhausern AT Aoyagi L Kerr MB Bromberg KJ Hart T Tuohy S White JT den Dunnen RB Weiss KM Flanigan 2005 Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort Am J Med Genet A 134 295 298 15723292 1:STN:280:DC%2BD2M7lsVCntA%3D%3D
42. JE Desmedt S Borenstein 1976 Regeneration in Duchenne muscular dystrophy. Electromyographic evidence Arch Neurol 33 642 650 962646 1:STN:280: DyaE283nslansg%3D%3D 10.1001/archneur.1976.00500090048010
43. JY Devaux L Cabane M Esler H Flaouters D Duboc 1993 Non-invasive evaluation of the cardiac function in golden retriever dogs by radionuclide angiography Neuromuscul Disord 3 429 432 8186687 1:STN:280:DyaK2c3ktlaksA%3D%3D 10.1016/0960-8966(93)90090-7
44. RH Edwards DA Jones DJ Newham SJ Chapman 1984 Role of mechanical damage in the pathogenesis of proximal myopathy in man Lancet 1 548 552 6142261 1:STN:280:DyaL2c7ktVOjsA%3D%3D 10.1016/S0140-6736(84)90941-3
45. B Emeryk-Szajewska J Kopeć 2008 Electromyographic pattern in Duchenne and Becker muscular dystrophy. Part I: Electromyographic pattern in subsequent stages of muscle lesion in Duchenne muscular dystrophy Electromyogr Clin Neurophysiol 48 265 277 18837192 1:STN:280:DC%2BD1cnksFagsA%3D%3D
46. Engel AG, Ozawa E (2004) Dystrophinopathies. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, Basic and Clinical. New York, pp 961-1025
47. Y Fan M Maley M Beilharz M Grounds 1996 Rapid death of injected myoblasts in myoblast transfer therapy Muscle Nerve 19 853 860 8965839 1:STN:280:DyaK283kslGltA%3D%3D 10.1002/(SICI)1097-4598(199607)19:7<853::AID- MUS7>3.0.CO;2-8
48. Fan Z, Kocis K, Valley R, Howard JF, Chopra M, An H, Lin W, Muenzer J, Powers W (2011) Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy. Mol Ther. doi: 10.1038/mt.2011.137
49. A Ferlini C Sewry MA Melis A Mateddu F Muntoni 1999 X-linked dilated cardiomyopathy and the dystrophin gene Neuromuscul Disord 9 339 346 10407857 1:STN:280:DyaK1Mzjs1Wqtw%3D%3D 10.1016/S0960-8966(99)00015-2
50. DM Fine J-H Shin Y Yue D Volkmann SB Leach BF Smith M McIntosh D Duan 2011 Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs Neuromusc Disord 21 7 453 461 21570848 10.1016/j.nmd.2011.03.010
51. KM Flanigan DM Dunn A von Niederhausern P Soltanzadeh E Gappmaier MT Howard JB Sampson JR Mendell C Wall WM King A Pestronk JM Florence AM Connolly KD Mathews CM Stephan KS Laubenthal BL Wong PJ Morehart A Meyer RS Finkel CG Bonnemann L Medne JW Day JC Dalton MK Margolis VJ Hinton 2009 Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort Hum Mutat 30 1657 1666 19937601 1:CAS:528:DC%2BC3cXkvFOmsA%3D%3D 10.1002/humu.21114
52. JM Gillis 1999 Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse J Muscle Res Cell Motil 20 605 625 10672510 1:CAS:528:DC%2BD3cXht1Cmurw%3D 10.1023/A:1005545325254
53. R Gilbert J Nalbantoglu JM Howell L Davies S Fletcher A Amalfitano BJ Petrof A Kamen B Massie G Karpati 2001 Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene productsDystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene products Hum Gene Ther 12 1741 1755 11560768 1:CAS:528:DC%2BD3MXntFWiur8%3D 10.1089/104303401750476249
54. Goyenvalle A, Seto JT, Davies KE, Chamberlain J (2011) Therapeutic approaches to muscular dystrophy. Hum Mol Genet 20(R1):R69-R78
55. Griggs RC, Moxley RT 3rd, Mendell JR, Fenichel GM, Dr. Brooke MH, Miller PJ, Mandel S, Florence J, Schierbecker J, Kaiser KK, King W, Pandya S, Robison J, Signore L (1990) Randomized, double-blind trial of maziindol in Duchenne dystrophy. Muscle Nerve 13:1169-1173
56. E Gussoni HM Blau LM Kunkel 1997 The fate of individual myoblasts after transplantation into muscles of DMD patients Nat Med 3 970 977 9288722 1:CAS:528:DyaK2sXlvVynurk%3D 10.1038/nm0997-970
57. JN Haslett D Sanoudou AT Kho M Han RR Bennett KS Kohane AH Beggs LM Kunkel 2003 Gene expression profiling of Duchenne muscular dystrophy skeletal muscle Neurogenetics 4 163 171 12698323 1:CAS:528:DC%2BD3sXms12gurs%3D 10.1007/s10048-003-0148-x
58. P Hilton-Brown E Stålberg J Trontelj M Mihelin 1985 Causes of the increased fiber density in muscular dystrophies studied with single fiber EMG during electrical stimulation Muscle Nerve 8 383 388 16758584 1:STN:280:DC%2BD28zksFWrsg%3D%3D 10.1002/mus.880080507
59. EP Hoffman RH Brown LM Kunkel 1987 Dystrophin: the protein product of the Duchenne muscular dystrophy locus Cell 51 919 928 3319190 1:CAS:528: DyaL1cXntlWqug%3D%3D 10.1016/0092-8674(87)90579-4
60. SM Holloway DE Wilcox A Wilcox JCS Dean JN Berg DR Goudie MA Denvir MEM Porteous 2008 Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland Heart 94 633 636 17932095 1:STN:280:DC%2BD1c3kvVCrtA%3D%3D 10.1136/hrt.2007.125948
61. JA Holzwarth RP Middleton M Roberts R Mansourian F Raymond SS Hannah 2005 The development of a high-density canine microarray J Hered 96 817 820 16269624 1:CAS:528:DC%2BD2MXht1ent7nL 10.1093/jhered/esi130
62. EM Hoogerwaard PA van der Wouw AAM Wilde E Bakker PF Ippel JC Oosterwijk DF Majoor-Krakauer AJ van Essen NJ Leschot M de Visser 1999 Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy Neuromuscul Disord 9 347 351 10407858 1:STN:280:DyaK1Mzjs1WqtA%3D%3D 10.1016/S0960-8966(99)00018-8
63. AL Hopkins JF Howard SJ Wheeler JN Kornegay 1993 Stimulated single fibre electromyography in normal dogs J Small Anim Pract 34 271 276 10.1111/j.1748-5827.1993.tb02685.x
64. JM Howell S Fletcher A O'Hara RD Johnsen F Lloyd BA Kakulas 1998 Direct dystrophin and reporter gene transfer into dog muscle in vivo Muscle Nerve 21 159 165 9466590 1:CAS:528:DyaK1MXisFals74%3D 10.1002/(SICI)1097-4598(199802)21: 2<159::AID-MUS2>3.0.CO;2-A
65. JM Howell H Lochmuller A O'Hara S Fletcher BA Kakulas B Massie J Nalbantoglu G Karpati 1998 High-level dystrophin expression after adenovirus mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with imunosuppression Hum Gene Ther 9 629 634 9551611 1:CAS:528:DyaK1cXit1ersbc%3D 10.1089/hum.1998.9.5-629
66. H Ito JT Vilquin D Skuk B Roy M Goulet S Lille FJ Dugré I Asselin R Roy M Fardeau JP Tremblay 1998 Myoblast transplantation in non-dystrophic dog Neuromuscul Disord 8 95 110 9608563 1:STN:280:DyaK1c3ntFCqsg%3D%3D 10.1016/S0960-8966(97)00148-X
67. G Jaegger DJ Marcellin-Little D Levine 2002 Reliability of goniometry in Labrador retrievers Am J Vet Res 63 979 986 12118679 10.2460/ajvr.2002.63.979
68. JL Jefferies BW Eidem JW Belmont WJ Craigen SM Ware SD Fernback SR Neish EO Smith JA Towbin 2005 Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy Circulation 112 2799 2804 16246949 10.1161/CIRCULATIONAHA.104.528281
69. BR Jones S Brennan CT Mooney JJ Callahan H McAllister LT Guo PT Martin E Engvall GD Shelton 2004 Muscular dystrophy with truncated dystrophin in a family of Japanese Spitz dogs J Neurol Sci 217 143 149 14706216 1:CAS:528: DC%2BD3sXhtVWisrrP 10.1016/j.jns.2003.09.002
70. G Karpati D Ajdukovic D Arnold RB Gledhill R Guttmann P Holland PA Koch E Shoubridge D Spence M Vanasse GV Watters M Abrahamowicz C Duff RG Worton 1993 Myoblast transfer in Duchenne muscular dystrophy Ann Neurol 34 8 17 8517684 1:STN:280:DyaK3s3psl2jug%3D%3D 10.1002/ana.410340105
71. Kellman P, Hernando D, Shah S, Hoyt RF Jr., Kotin R, Keene BW, Kornegay JN, Aletras AH, Arai AE (2009) Myocardial fibro-fatty infiltration in duchenne muscular dystrophy canine model detected using multi-echo Dixon method of water and fat separation imaging. In: ISMRM 2009. http://dir.nhlbi.nih.gov/staffpages/ kellmanp/abstracts/ISMRM2009-03762.pdf
72. I Kerkis CE Ambrósio A Kerkis DS Martins E Zucconi SAS Fonseca RM Cabral CMC Maranduba TP Gaiad AC Morini NM Vieira MP Brolio OA Sant' Anna MA Miglino M Zatz 2008 Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic? J Transl Med 6 35 18598348 10.1186/1479-5876-6-35 1:CAS:528:DC%2BD1cXht1KhtLrF
73. C Knowler SJ Wheeler 1995 Neospora caninum infection in three dogs J Small Anim Pract 36 172 177 7603059 1:STN:280:DyaK2Mzis1Kgtg%3D%3D 10.1111/j.1748-5827.1995.tb02875.x
74. M Kobayashi A Nakamura D Hasegawa M Fujita H Orima S Takeda 2009 Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging Muscle Nerve 40 815 826 19670324 10.1002/mus.21384
75. GY Koh MH Soonpaa MG Klug HP Pride BJ Cooper DP Zipes LJ Field 1995 Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs J Clin Invest 96 2034 2042 7560097 1:CAS:528:DyaK2MXosFyhtLs%3D 10.1172/JCI118251
76. JN Kornegay SM Tuler DM Miller DC Levesque 1988 Muscular dystrophy in a litter of golden retriever dogs Muscle Nerve 11 1056 1064 3185600 1:STN:280:DyaL1M%2FktVSjsw%3D%3D 10.1002/mus.880111008
77. Kornegay JN, Prattis SM, Bogan DJ, Sharp NJH, Bartlett RJ, Alameddine HS, Dykstra MJ (1992) Results of myoblast transplantation in a canine model of muscle injury. In: Kakulas BA, Howell JMc, Roses AD (eds) Duchenne Muscular Dystrophy. Animal Models and Genetic Manipulation. Raven Press, San Diego, pp 203-212
78. JN Kornegay NJ Sharp DJ Bogan SD Van Camp JR Metcalf RO Schueler 1994 Contraction tension and kinetics of the peroneus longus muscle in golden retriever muscular dystrophy J Neurol Sci 123 100 107 8064300 1:STN:280:DyaK2czkt12iug%3D%3D 10.1016/0022-510X(94)90210-0
79. JN Kornegay NJ Sharp RO Schueler CW Betts 1994 Tibiotarsal joint contracture in dogs with golden retriever muscular dystrophy Lab Anim Sci 44 331 333 7983843 1:STN:280:DyaK2M%2FnsFSjtQ%3D%3D
80. JN Kornegay DJ Bogan JR Bogan MK Childers DD Cundiff GF Petroski RO Schueler 1999 Contraction force generated by tibiotarsal joint flexion and extension in dogs with golden retriever muscular dystrophy J Neurol Sci 166 115 121 10475104 1:STN:280:DyaK1Mvgt1Sruw%3D%3D 10.1016/S0022-510X(99)00118-5
81. JN Kornegay DD Cundiff DJ Bogan JR Bogan CS Okamura 2003 The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy Neuromuscul Disord 13 493 500 12899877 10.1016/S0960-8966(03) 00025-7
82. JN Kornegay J Li JR Bogan DJ Bogan C Chen H Zheng B Wang C Qiao JF Howard Jr X Xiao 2010 Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs Mol Ther 18 1501 1508 20517298 1:CAS:528:DC%2BC3cXmslWmtLc%3D 10.1038/mt.2010.94
83. Kornegay JN, Bogan JR, Bogan DJ, Childers MK, Grange RW (2011) Golden retriever muscular dystrophy (GRMD): Developing and maintaining a colony and physiological functional measurements. In: Duan D (ed) Muscle Gene Therapy: Methods and Protocols. Methods in Molecular Biology, vol 709. Humana Press, New York, pp 105-123
84. AE Lamminen 1990 Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement Br J Radiol 63 946 950 2268764 1:STN:280:DyaK3M%2FpvVertQ%3D%3D 10.1259/0007-1285-63-756-946
85. M Lanfossi F Cozzi D Bugini S Colombo P Scarpa L Morandi S Galbiati F Cornelio O Pozza M Mora 1999 Development of muscle pathology in canine X-linked muscular dystrophy. I. Delayed postnatal maturation of affected and normal muscle as revealed by myosin isoform analysis and utrophin expression Acta Neuropathol 97 127 138 9928823 1:CAS:528:DyaK1cXnvFOgt7o%3D 10.1007/ s004010050965
86. SJ Lee 2004 Regulation of muscle mass by myostatin Annu Rev Cell Dev Biol 20 61 86 15473835 1:CAS:528:DC%2BD2cXhtVaqu7nF 10.1146/annurev.cellbio.20. 012103.135836
87. SJ Lee AC McPherron 1999 Myostatin and the control of skeletal muscle mass Curr Opin Genet Dev 9 604 607 10508689 1:CAS:528:DyaK1MXntlOhsr0%3D 10.1016/S0959-437X(99)00004-0
88. J Li J Bogan C Chen D Bogan B Wang Z Yuan C Qiao JN Kornegay X Xiao 2009 Hydrodynamic limb vein injection of AAV9 results in regional and systemic long-term expression of minidystrophin in young adult GRMD dogs Mol Ther 17 S1 S278
89. GC Liu YJ Jong CH Chiang TS Jaw 1993 Duchenne muscular dystrophy: MR grading system with functional correlation Radiology 186 475 480 8421754 1:STN:280:DyaK3s7jsVSmuw%3D%3D
90. JM Liu CS Okamura DJ Bogan JR Bogan MK Childers JN Kornegay 2004 Effects of prednisone in canine muscular dystrophy Muscle Nerve 30 767 773 15468337 10.1002/mus.20154
91. S Lovitt SL Moore FA Marden 2006 The use of MRI in the evaluation of myopathy Clin Neurophysiol 117 486 495 16443389 10.1016/j.clinph.2005.10.010
92. S Malhotra K Hart H Klamut N Thomas S Bodrug A Burghes M Bobrow P Harper M Thompson P Ray R Worton 1988 Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy Science 242 755 759 3055295 1:CAS:528:DyaL1MXitVyh 10.1126/science.3055295
93. FA Marden AM Connolly MJ Siegel DA Rubin 2005 Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging Skeletal Radiol 34 140 148 15538561 10.1007/s00256-004-0825-3
94. AP Marsh JD Eggebeen JN Kornegay CD Markert MK Childers 2010 Kinematics of gait in golden retriever muscular dystrophy Neuromuscul Disord 20 16 20 19932618 10.1016/j.nmd.2009.10.007
95. CM McDonald EK Henricson JJ Han RT Abresch A Nicorici GL Elfring L Atkinson A Reha S Hirawat LL Miller 2010 The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy Muscle Nerve 41 500 510 19941337 10.1002/mus.21544
96. AC McPherron SJ Lee 2002 Suppression of body fat accumulation in myostatin-deficient mice J Clin Invest 109 595 601 11877467 1:CAS:528: DC%2BD38XitVeqt7Y%3D
97. AC McPherron AM Lawler SJ Lee 1997 Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member Nature 387 83 90 9139826 1:CAS:528:DyaK2sXivFygur0%3D 10.1038/387083a0
98. P Melacini M Fanin GA Danieli C Villanova F Martinello M Miorin MP Freda M Mioreelli ML Mostacciuolo G Fasoli C Angelini SD Volta 1996 Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy Circulation 94 3168 3175 8989125 1:STN:280: DyaK2s7ktlWitg%3D%3D
99. JR Mendell K Campbell L Rodino-Klapac Z Sahenk C Shilling S Lewis D Bowles S Gray C Li G Galloway V Malik B Coley KR Clark J Li X Xiao J Samulski SW McPhee RJ Samulski CM Walker 2010 Dystrophin immunity in Duchenne's muscular dystrophy N Engl J Med 363 1429 1437 20925545 1:CAS:528:DC%2BC3cXhtlGksL%2FI 10.1056/NEJMoa1000228
100. G Meola 2005 Advanced microscopic and histochemical techniques: diagnostic tools in the molecular era of myology Eur J Histochem 49 93 96 15823800 1:STN:280:DC%2BD2M3htVShsA%3D%3D
101. RG Miller KR Sharma GK Pavlath E Gussoni M Mynhier P Yu AM Lanctot CM Greco L Steinman H Blau 1997 Myoblast transplantation in Duchenne muscular dystrophy: The San Francisco Study Muscle Nerve 20 469 478 9121505 1:STN:280:DyaK2s3ksVegsg%3D%3D 10.1002/(SICI)1097-4598(199704)20:4<469::AID- MUS10>3.0.CO;2-U
102. MG Minasi M Riminucci L De Angelis U Borello B Berarducci A Innocenzi A Caprioli D Sirabella M Baiocchi R De Maria R Boratto T Jaffredo V Broccoli P Bianco G Cossu 2002 The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues Development 129 2773 2783 12015303 1:CAS:528:DC%2BD38XltVyhtro%3D
103. LG Miyazato JRE Moraes DC Baretta JN Kornegay 2011 Muscular dystrophy in dogs: Does the crossing of different breeds influence disease phenotype? Vet Pathol 48 655 662 21233328 1:STN:280:DC%2BC3MvpsVGmug%3D%3D 10.1177/ 0300985810387070
104. P Moens PHWW Baatsen G Maréchal 1993 Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch J Muscle Res Cell Motil 14 446 451 7693747 1:STN:280:DyaK2c%2FktlKrtA%3D%3D 10.1007/BF00121296
105. NS Moise BA Valentine CA Brown HN Erb KA Beck BJ Cooper RF Gilmour 1991 Duchenne's cardiomyopathy in a canine model: Electrocardiographic and echocardiographic studies J Am Coll Cardiol 17 812 820 1825214 1:STN:280:DyaK3M7jtF2hsQ%3D%3D 10.1016/S0735-1097(10)80202-5
106. DS Mosher P Quignon CD Bustamante NB Sutter CS Mellersh HG Parker EA Ostrander 2007 A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs PLoS Genet 3 779 786 1:CAS:528:DC%2BD2sXnvVWgsrg%3D 10.1371/journal.pgen.0030079
107. F Muntoni 2003 Cardiomyopathy in muscular dystrophies Curr Opin Neurol 16 577 583 14501841 10.1097/00019052-200310000-00003
108. Nagaraju K, Willmann R, TREAT-NMD Network and the Wellstone Muscular Dystrophy Cooperative Research Network (2009) Developing standard procedures for murine and canine efficacy studies of DMD therapeutics: report of two expert workshops on "Pre-clinical testing for Duchenne dystrophy": Washington DC, October 27th-28th 2007 and Zürich, June 30th-July 1st 2008. Neuromuscul Disord 19:502-506
109. K Nakagaki DH Gebhard DJ Bogan JN Kornegay 1994 A quantitative comparison of NCAM-positive muscle cells from normal and dystrophic dogs Muscle Nerve 17 Suppl 1 S193
110. K Nakagaki DH Gebhard DJ Bogan JN Kornegay 1994 Selection of canine myogenic cells with panning Muscle Nerve 17 Suppl 1 S260
111. SD Nandedkar PE Barkhaus A Charles 1995 Multi-motor unit action potential analysis (MMA) Muscle Nerve 10 1155 1166 10.1002/mus.880181012
112. F Nguyen Y Cherel L Guigand I Goubault-Leroux M Wyers 2002 Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies J Comp Pathol 126 100 108 11944998 1:STN:280:DC%2BD383ht1Wktg%3D%3D 10.1053/jcpa.2001.0526
113. HL Nicholson PG Osmotherly BA Smith CM McGowan 2007 Determinants of passive hip range of motion in adult Greyhounds Aust Vet J 85 217 221 17547633 1:STN:280:DC%2BD2szjsFOrsQ%3D%3D 10.1111/j.1751-0813.2007.00145.x
114. G Nigro LI Comi L Politano FM Limongelli V Nigro ML Rimini MAM Giugliano VR Petretta L Passamano B Restucci L Fattore K Tebloev L Comi F De Luca P Raia M Esposito 1995 Evaluation of the cardiomyopathy in Becker muscular dystrophy Muscle Nerve 18 283 291 7870105 1:STN:280:DyaK2M7nsVyjug%3D%3D 10.1002/mus.880180304
115. S Ohshima J-H Shin K Yuasa A Nishiyama J Kira T Okada S Takeda 2009 Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle Mol Ther 17 73 80 18941441 1:CAS:528:DC%2BD1cXhsFCkurbF 10.1038/mt.2008.225
116. MH Parker C Kuhr SJ Tapscott R Storb 2008 Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs Mol Ther 16 1340 1346 18500253 1:CAS:528:DC%2BD1cXns1eiurg%3D 10.1038/mt.2008.102
117. T Partridge 2002 Myoblast transplantation Neuromuscul Disord 12 Suppl 1 S3 S6 12206788 10.1016/S0960-8966(02)00076-7
118. TA Partridge M Grounds JC Sloper 1978 Evidence of fusion between host and donor myoblasts in skeletal muscle grafts Nature 273 306 308 652035 1:STN:280:DyaE1c7nslahsA%3D%3D 10.1038/273306a0
119. TA Partridge JE Morgan GR Coulton EP Hoffman LM Kunkel 1989 Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts Nature 337 176 179 2643055 1:STN:280:DyaL1M%2Fpslamtg%3D%3D 10.1038/337176a0
120. BA Phillips LA Cala GW Thickbroom A Melsom PJ Zilko FL Mastaglia 2001 Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study Muscle Nerve 24 1526 1534 11745956 1:STN:280: DC%2BD3MnpsFygtg%3D%3D 10.1002/mus.1178
121. C Pichavant P Chapdelaine DG Cerri JC Dominique SP Quenneville D Skuk JN Kornegay JC Bizario X Xiao JP Tremblay 2010 Expression of dog microdystrophin in mouse and dog muscles by gene therapy Mol Ther 18 1002 1009 20179674 1:CAS:528:DC%2BC3cXitlait70%3D 10.1038/mt.2010.23
122. JD Porter S Khanna HJ Kaminski JS Rao AP Merriam CR Richmonds P Leahy J Li W Guo FH Andrade 2002 A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice Hum Mol Genet 11 263 272 11823445 1:CAS:528:DC%2BD38XhvVejs74%3D 10.1093/hmg/11.3.263
123. SM Prattis DH Gebhart G Dickson DJ Watt JN Kornegay 1993 Magnetic affinity cell sorting (MACS) separation and flow cytometric characterization of neural cell adhesion molecule-positive, cultured myogenic cells from normal and dystrophic dogs Exp Cell Res 208 453 464 8375474 1:CAS:528:DyaK2cXjvVSj 10.1006/excr.1993.1267
124. TW Prior SJ Bridgeman 2005 Experience and strategy for the molecular testing of Duchenne muscular dystrophy J Mol Diag 7 317 326 1:CAS:528: DC%2BD2MXhtVWjtLnI 10.1016/S1525-1578(10)60560-0
125. C Qiao J Li H Zheng J Bogan J Li Z Yuan C Zhang D Bogan J Kornegay X Xiao 2009 Hydrodynamic limb vein injection of AAV8 canine myostatin propeptide gene in normal dogs enhances muscle growth Hum Gene Ther 20 1 10 18828709 1:CAS:528:DC%2BD1MXhtVehtbY%3D 10.1089/hum.2008.135
126. Rideau Y (1984) Treatment of orthopedic deformity during the ambulation stage of Duchenne muscular dystrophy. In: Serratrice G (ed) Neuromuscular Diseases. Raven Press, New York, pp 557-564
127. K Rouger T Larcher L Dubreil JY Deschamps C Le Guiner G Jouvion B Delorme B Lieubeau M Carlus B Fornasari M Theret P Orlando M Ledevin C Zuber I Leroux S Deleau L Guigand I Testault E Le Rumeur M Fiszman Y Chérel 2011 Systemic delivery of allogenic muscle stem (MuStem) cells Induces Long-Term Muscle repair and clinical efficacy in Duchenne muscular dystrophy dogs Am J Pathol 179 5 2501 2518 21924229 1:CAS:528:DC%2BC3MXhsFCmu7jO 10.1016/j.ajpath.2011.07.022
128. M Saito H Kawai M Akaike K Adachi Y Nishida S Saito 1996 Cardiac dysfunction with Becker muscular dystrophy Am Heart J 132 642 647 8800037 1:STN:280:DyaK28zptlamsg%3D%3D 10.1016/S0002-8703(96)90250-1
129. MC Salimena J Lagrota-Candido T Quírico-Santos 2004 Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice Histochem Cell Biol 122 535 544
130. M Sampaolesi S Blot G D'Antona N Granger R Tonlorenzi A Innocenzi P Mognol JL Thibaud BG Galvez I Barthelemy L Perani S Mantero M Guttinger O Pansarasa C Rinaldi MG Cusella De Angelis Y Torrente C Bordingnon R Bottinelli G Cossu 2006 Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs Nature 444 574 579 17108972 1:CAS:528:DC%2BD28Xht1KjurjO 10.1038/nature05282
131. DB Sanders EV Stalberg 1996 AAEM minimonogaph #25: Single-fiber electromyography Muscle Nerve 19 1069 1083 8761262 1:STN:280: DyaK28zlsFOkuw%3D%3D 10.1002/(SICI)1097-4598(199609)19:9<1069::AID-MUS1>3. 0.CO;2-Y
132. SJ Schatzberg NJ Olby M Breen LV Anderson CF Langford HF Dickens SD Wilton CJ Zeiss MM Binns JN Kornegay GE Morris NJ Sharp 1999 Molecular analysis of a spontaneous dystrophin "knockout" dog Neuromuscul Disord 9 289 295 10407848 1:STN:280:DyaK1Mzjs1WrtA%3D%3D 10.1016/S0960-8966(99)00011-5
133. J Selsby K Pendrak M Zadel Z Tian J Pham T Carver P Acosta E Barton HL Sweeney 2010 Leupeptin-based inhibitors do not improve the mdx phenotype Am J Physiol Regul Integr Comp Physiol 299 R1192 R1201 20844259 1:CAS:528: DC%2BC3cXhsFSktL%2FF 10.1152/ajpregu.00586.2009
134. NJ Sharp JN Kornegay SD Van Camp MH Herbstreith SL Secore S Kettle WY Hung CD Constantinou MJ Dykstra AD Roses RJ Bartlett 1991 An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy Genomics 13 115 121 10.1016/0888-7543(92)90210-J
135. J) Exp Anim 52 93 97 12806883 1:CAS:528:DC%2BD3sXktlWjsrg%3D 10.1538/expanim.52.93
136. Y Shimatsu M Yoshimura K Yuasa N Urasawa M Tomohiro M Nakura M Tanigawa A Nakamura S Takeda 2005 Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ Acta Myol 24 145 154 16550932 1:CAS:528:DC%2BD28Xis1yitLs%3D
137. IM Siegel JE Miller RD Ray 1968 Subcutaneous lower limb tenotomy in the treatment of pseudohypertrophic muscular dystrophy J Bone Joint Surg 50A 1437 1443
138. D Skuk M Paradis M Goulet JP Tremblay 2007 Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies Transplantation 84 1307 1315 18049116 10.1097/01.tp.0000288322.94252.22
139. BF Smith JN Kornegay D Duan 2007 Independent canine models of Duchenne muscular dystrophy due to intronic insertions of repetitive DNA Mol Ther 15 Suppl 1 S51
140. BF Smith Y Yue PR Woods JN Kornegay JH Shin RR Williams D Duan 2011 An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the Corgi breed Lab Invest 91 216 231 20714321 1:CAS:528:DC%2BC3MXhtlaru7w%3D 10.1038/labinvest.2010.146
141. GM Smythe SI Hodgetts MD Grounds 2001 Problems and solutions in myoblast transfer therapy J Cell Mol Med 5 33 47 12067449 1:CAS:528:DC%2BD3MXjslKmsb8%3D 10.1111/j.1582-4934.2001.tb00136.x
142. MJ Spencer DE Croall JG Tidball 1995 Calpains are activated in necrotic fibers from mdx dystrophic mice J Biol Chem 270 10909 10914 7738032 1:CAS:528:DyaK2MXlsFKrsr4%3D 10.1074/jbc.270.34.19816
143. CJ Tegeler RW Grange DJ Bogan CD Markert D Case JN Kornegay MK Childers 2010 Eccentric contractions induce rapid isometric torque drop in dystrophic-deficient dogs Muscle Nerve 42 130 132 20544944 10.1002/mus.21699
144. JL Thibaud A Monnet D Dertoldi I Barthelemy S Blot PG Carlier 2007 Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging Neuromuscul Disord 17 575 584 17537632 10.1016/j.nmd.2007.03.013
145. D Townsend I Turner S Yasuda J Martindale J Davis M Shillingford JN Kornegay JM Metzger 2010 Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs J Clin Invest 120 1050 1140 10.1172/JCI41329 1:CAS:528:DC%2BC3cXksVChsLg%3D
146. JP Tremblay F Malouin R Roy J Huard JP Bouchard A Satoh CL Richards 1993 Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy Cell Transplant 2 99 112 8143083 1:STN:280:DyaK2c7ptF2jtg%3D%3D
147. BA Valentine BJ Cooper A de Lahunta R O'Quinn JT Blue 1988 Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies J Neurol Sci 88 69 81 3225630 1:STN:280:DyaL1M7ktV2jsA%3D%3D 10.1016/0022-510X(88)90206-7
148. BA Valentine JF Cummings BJ Cooper 1989 Development of Duchenne-type cardiomyopathy. Morphologic studies in a canine model Am J Pathol 135 671 678 2679113 1:STN:280:DyaK3c%2FitlOltA%3D%3D
149. BA Valentine JN Kornegay BJ Cooper 1989 Clinical electromyography studies of canine X-linked muscular dystrophy Am J Vet Res 50 2145 2147 2610444 1:STN:280:DyaK3c7itValtQ%3D%3D
150. BA Valentine BJ Cooper JF Cummings A de Lahunta 1990 Canine X-linked muscular dystrophy: morphologic lesions J Neurol Sci 97 1 23 2370557 1:STN:280:DyaK3czhslKgsw%3D%3D 10.1016/0022-510X(90)90095-5
151. Vieira NM, Valadares M, Zucconi E, Secco M, Bueno CR, Brandalise V, Assoni A, Gomes J, Landini V, Andrade T, Caetano HV, Vainzof M, Zatz M (2011) Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin. Cell Transplant 2011 Oct 14 [Epub ahead of print]
152. PJ Vignos Jr KC Archibald 1960 Maintenance of ambulation in childhood muscular dystrophy J Chron Dis 12 273 290 13842210 10.1016/0021-9681(60)90105-3
153. PJ Vignos Jr GE Spencer Jr JC Archibald 1963 Management of muscular dystrophy of childhood JAMA 184 89 96 13997180 10.1001/jama.1963.03700150043007
154. KM Wadosky L Li JE Rodríguez J Min D Bogan J Gonzalez JN Kornegay M Willis 2011 Regulation of the calpain and ubiquitin proteasome systems in a canine model of Duchenne muscular dystrophy Muscle Nerve 44 4 553 562 21826685 1:CAS:528:DC%2BC3MXhtFOitLvP 10.1002/mus.22125
155. KR Wagner AC McPherron N Winik SJ Lee 2002 Loss of myostatin attenuates severity of muscular dystrophy in mdx mice Ann Neurol 52 832 836 12447939 1:CAS:528:DC%2BD38Xps1OqsL0%3D 10.1002/ana.10385
156. KR Wagner X Liu X Chang RE Allen 2005 Muscle regeneration in the prolonged absence of myostatin Proc Natl Acad Sci USA 102 2519 2524 15699335 1:CAS:528:DC%2BD2MXhvFKiur8%3D 10.1073/pnas.0408729102
157. GL Walmsley V Arechavala-Gomeza M Fernandez-Fuente MM Burke N Nagel A Holder R Stanley K Chandler SL Marks F Muntoni GD Shelton RJ Piercy 2010 A Duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient Cavalier King Charles spaniels is amenable to exon 51 skipping PloS One 5 1 e8647 20072625 10.1371/journal.pone.0008647 1:CAS:528:DC%2BC3cXpvVWnsQ%3D%3D
158. Z Wang JM Allen SR Riddell P Gregorevic R Storb SJ Tapscott JS Chamberlain CS Kuhr 2007 Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy Hum Gene Ther 18 18 26 17176210 10.1089/hum.2006.093 1:CAS:528:DC%2BD2sXptlKqsw%3D%3D
159. Z Wang CS Kuhr JM Allen M Blankenship P Gregorevic JS Chamberlain SJ Tapscott R Storb 2007 Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression Mol Ther 15 1160 1166 17426713 1:CAS:528:DC%2BD2sXhtVejtr%2FE
160. B Wang J Li FH Fu X Xiao 2009 Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin- deficient mice J Orthop Res 27 421 426 18973234 10.1002/jor.20781
161. Z Wang R Storb D Lee MJ Kushmerick B Chu C Berger A Arnett J Allen JS Chamberlain SR Riddell SJ Tapscott 2010 Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging Mol Ther 18 617 624 20040912 1:CAS:528:DC%2BD1MXhs1WntrrO 10.1038/mt.2009.294
162. Wang J, Fan Z, Kornegay JN, Styner MA (2011) MRI-based quantification of Duchenne muscular dystrophy in a canine model. Proc SPIE 7965:0G1-9
163. Winand N, Pradham D, Cooper B (1994) Molecular characterization of severe Duchenne-type muscular dystrophy in a family of Rottwiler dogs. In: Molecular mechanism of neuromuscular disease. Muscular Dystrophy Association, Tucson
164. AV Winnard CJ KIein DD Coovert T Prior A Papp P Snyder DE Bulman PN Ray P McAndrew W King RT Moxley JR Mendel AHM Burghes 1993 Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy Hum Mol Genet 2 737 744 8353493 1:CAS:528:DyaK3sXlsFOmtLw%3D 10.1093/hmg/2.6.737
165. K Wulff FH Herrmann MC Wapenaar M Wehner 1989 Deletion screening in patients with Duchenne muscular dystrophy J Neurol 236 470 473 2614492 1:STN:280:DyaK3c7jt1yisQ%3D%3D 10.1007/BF00328509
166. T Yokota QL Lu T Partridge M Kobayashi A Nakamura S Takeda E Hoffman 2009 Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs Ann Neurol 65 667 676 19288467 10.1002/ana.21627
167. K Yuasa M Yoshimura N Urasawa S Ohshima JM Howell A Nakamura T Hijikata Y Miyagoe-Suzuki S Takeda 2007 Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products Gene Ther 14 1249 1260 17581597 1:CAS:528:DC%2BD2sXpt1alurw%3D 10.1038/sj.gt.3302984
168. Y Yue A Ghosh C Long B Bostick BF Smith JN Kornegay D Duan 2008 A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs Mol Ther 16 1944 1952 18827804 1:CAS:528:DC%2BD1cXhsVSjsbvE 10.1038/mt.2008.207
169. N Yugeta N Urasawa Y Fujii M Yoshimura K Yuasa MR Wada M Nakura Y Shimatsu M Tomohiro A Takahashi N Machida Y Wakao A Nakaura S Takeda 2006 Cardiac involvement in Beagle-based canine x-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies BMC Cardiovasc Disord 6 47 59 17140458 10.1186/1471-2261-6-47 1:CAS:528: DC%2BD2sXhvFChtbk%3D
170. PA Yushkevich J Piven HC Hazlett RG Smith S Ho JC Gee G Gerig 2006 User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability Neuroimage 31 1116 1128 16545965 10.1016/j.neuroimage.2006.01.015
171. M Zatz RT Betti JA Levy 1981 Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency Am J Med Genet 10 301 304 7304674 1:STN:280:DyaL38%2FmsFKjtg%3D%3D 10.1002/ajmg.1320100313
172. E Zucconi NM Vieira CR Bueno Jr M Secco T Jazedje M Costa Valadares M Fussae Suzuki P Bartolini M Vainzof M Zatz 2011 Preclinical studies with umbilical cord mesenchymal stromal cells in different animal models for muscular dystrophy J Biomed Biotechnol 2011 715251 21785565 10.1155/2011/715251 1:CAS:528:DC%2BC3MXhtVCgurrL